Low concentration structural dynamics of lanreotide and somatostatin-14

about

From bulk to plasmonic nanoparticle surfaces: the behavior of two potent therapeutic peptides, octreotide and pasireotide

P2860

Q59153959-CEE9BABD-A150-4A14-A0E9-DB9CCB0E336F

P2860

Low concentration structural dynamics of lanreotide and somatostatin-14

Item

http://www.wikidata.org/entity/Q57162634

description

article

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2014

@uk

name

Low concentration structural dynamics of lanreotide and somatostatin-14

@en

Low concentration structural dynamics of lanreotide and somatostatin-14

@nl

type

Item

label

Low concentration structural dynamics of lanreotide and somatostatin-14

@en

Low concentration structural dynamics of lanreotide and somatostatin-14

@nl

prefLabel

Low concentration structural dynamics of lanreotide and somatostatin-14

@en

Low concentration structural dynamics of lanreotide and somatostatin-14

@nl

P1476

Low concentration structural dynamics of lanreotide and somatostatin-14

@en

P2093

Belén Hernández

http://www.w3.org/2001/XMLSchema#string

Bruno Baron

http://www.w3.org/2001/XMLSchema#string

Claude Carelli

http://www.w3.org/2001/XMLSchema#string

Fernando Pflüger

http://www.w3.org/2001/XMLSchema#string

Mahmoud Ghomi

http://www.w3.org/2001/XMLSchema#string

Régis Cohen

http://www.w3.org/2001/XMLSchema#string

Sergei G Kruglik

http://www.w3.org/2001/XMLSchema#string

Yves-Marie Coïc

http://www.w3.org/2001/XMLSchema#string

P2860

Multiconformational NMR analysis of sandostatin (octreotide): equilibrium between beta-sheet and partially helical structures

Somatostatin and its receptor family

Role of somatostatin analogs in the clinical management of non-neuroendocrine solid tumors

Probing the structural determinants of type II' beta-turn formation in peptides and proteins.

Peptide binding to lipid membranes. Spectroscopic studies on the insertion of a cyclic somatostatin analog into phospholipid bilayers.

Control of peptide nanotube diameter by chemical modifications of an aromatic residue involved in a single close contact.

Self-association process of a peptide in solution: from beta-sheet filaments to large embedded nanotubes.

Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone.

Biomimetic organization: Octapeptide self-assembly into nanotubes of viral capsid-like dimension.

Somatostatin conformation: evidence for a stable intramolecular structure from circular dichroism, diffusion, and sedimentation equilibrium

P304

1019-28

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/BIP.22491

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

101

http://www.w3.org/2001/XMLSchema#string

P577

2014-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24729416

http://www.w3.org/2001/XMLSchema#string

Low concentration structural dynamics of lanreotide and somatostatin-14

about

P2860

P2860

Low concentration structural dynamics of lanreotide and somatostatin-14

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698